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Epidermal Langerhans cells are critical for 
immunoregulation of cutaneous 
leishmaniasis 
Heidrun Moll 
In leishmaniasis, macrophages ar  known to play a central role as 
modulators of the speafic immune actiwty. In this artMe, Hetdrun Moll 
presents evidence for the crmcal involvement ofanother component of the 
skin immune system, the epMermal Langerhans cell. She proposes that 
Langerhans cells take up parasttes m the skin and transport hem to the 
draining lymph node for presentation to T cells and imtiatzon of the 
specific immune response. 
Human leishmaniasls comprises a &verse group of 
diseases caused by protozoa of the genus Lelshmama. 
The parasites belong to the famdy Trypanosomatidae; 
they alternate between the promastlgote form in the 
sandfly vector and the obligatory mtracellular amasn- 
gote form in the mammahan host. The diseases vary in 
seventy from the naturally heahng cutaneous lexsh- 
maniasis (oriental sore), which is characterized by a 
localized skin lesion at the site of the sandfly's bite, to 
the potennally fatal visceral lelshmaniasls (kala-azar), 
in which the parasites &sseminate from the site of 
refection and invade lymph nodes, spleen, liver and 
bone marrow. The chnical manffestanon depends pri- 
marily on the species of parasite, but it also revolves 
the generic bas!s of the host's abdity to develop an 
effective cell-medmted ~mmune response, thus resem- 
bling the situation in leprosy. 
The spectrum of disease patterns een m humans can 
be reproduced by experimental mfecnon of mxce with 
Letshmania malor, the cause of cutaneous leishman- 
iasis in the Old World. This mouse model has provided 
a wealth of informanon on the immune mechamsms 
underlying host resistance or suscepnbdlty o leishman- 
iasis, with lmphcanons for a number of mfecuous &s- 
eases. The outcome of murme refection with L. malor 
is not influenced by humoral immumty but appears to 
be determined by CD4 ÷ helper T cells (TH cells) with 
different patterns of lymphokme actiwty. Thus, protec- 
tive immumty can be attributed to THl-hke cells pro- 
ducing interferon-gamma (IFN-T), whereas TH2-hke 
cells releasing interleukm 4 (IL-4) and !L-10 facihtate 
survxval of the parasitesk On the other hand, the find- 
rags that L. malor-spec~fic THI cells can also exacer- 
bate disease-' and that local mlecnon of IL-4 has a thera- 
peunc effect 3 have emphasized the complexity of the 
interplay between the parasite and the host immune 
system. 
Early events in Leisbmania infection 
Resistance to L. malor refection can be induced m 
generically susceptible mice by various treatments, for 
example, sublethal irra&atlon, lmmumzanon with para- 
site antigen or treatment w~th anti-IL-4 antibodies. In 
most cases, however, such manipulanons are only 
effective if performed before refection r during the 
first week, probably because the dlffere,~_tlal stimu- 
latton of Tu-cell subsets ~s mmated w~thm three days 
after moculanon of parasttes 4. These fmdmgs empha- 
size the importance of the early phase of infection. 
The natural sxte of entry of Leishmama parasites 
into the mammahan host ~s the skin. It ~s here that the 
organisms invade host cells for mtracellular mulnph- 
cation and are first encountered by the immune system. 
In view of the above observations, It Is very likely that 
the cutaneous immune response at th~s mmal stage of 
infect:on is cruc:a! to the course of d:sease. Within a 
few hours after parasite inoculation, a massive cellular 
mfiltranon occurs consisting predominantly of macro- 
phages which rapidly take up parasites ~. The signals 
mediating the reflux of macrophages may include 
chemotact;c cytokmes uch as the monocyte chemo- 
attractant protein, MCP-1 (R. Gdhtzer, I. Becker and 
H. Moll, unpubhshed). On the basis of tn wtro and m 
wvo stu&es, tt ~s widely accepted that macrophages 
play a central role m lelshmaniasls 6. They serve not 
only as host cells for the parasites, but also as antigen- 
presenting cells mediating the snmulation of specific 
T cells. In return, lymphokmes released by activated 
T cells regulate he antimicrobial potenual of macro- 
phages which are the final effector cells for limitation 
of the deleterious spread of parasites. 
In the very early phase of mfecnon with Letshmama, 
there are few T cells m the dermal infiltrate ~. Thus, 
infected macrophages xpressing parasite antigen have
a low probabihty of encountering T cells wtth the cor- 
responding specfftcity reqmred for triggering the cell- 
mediated ~mmune response. It is necessary, therefore, 
to provide a principal sensitizing slgnal thatactivates 
antigen-speofic quiescent T cells m the lymphoid 
organs and reduces their emigranon wa the blood- 
stream to the lesional skin. Furthermore, to allow 
for effective anngen presentanon by macrophages, the 
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surface expression f malor htstocompatibihty com- 
plex (/VlHC) class II anngens has to be increased by 
sumulatory signals, such as IFN-7, that are predomi- 
nantly derived from activated T cells '~. These consider- 
auons indicate that macrophages may not suffice for 
induction and modulauon of the cell-medmted immune 
reactivity to Leisbmama parasites and other intra- 
cellular microorganisms invading the skin. In fact, the 
skin harbours cells with potent accessory capacity, epi- 
dermal Langerhans cells, which may represent he 
'missing link'. 
Langerhans cells - a component of the dendritic cell 
system 
Langerhans cells are derived from the bone marrow. 
They have a pronounced endritic shape and can be 
identified, at the ultrastructural level, by organelles in 
their cytoplasm, termed Birbeck granules (reviewed in 
Ref. 8). Phenotypically, Langerhans cells share some 
features with macrophages since they express surface 
markers such as ATPase, nonspecific esterase and 
receptors for Fc and for complement. ~n contrast o 
macrophages, however, Langerhans cells (in the 
mouse) react with a monoclonal antibody directed 
against nonlymphold dendritic ells (NLDC-145) (Ref. 
9), and they constitutively express sizeable amounts of 
MHC class II molecules. 
Langerhans cells are potent stimulators of antigen- 
specific and MHC-restncted T-cell responses 1°. In- 
terestingly, their functional properties m wtro are 
dependent on the state of differentiation n,n. Freshly 
isolated Langerhans cells can process native antigen for 
presentauon to prewously sensitized T cells, but are 
weak activators of resting T cells. During short-term 
culture, however, Langerhans cells lose their process- 
ing capacity and acquire the umque potent,al to induce 
or l ln~rv  i rn rn l lnP  re~nnn c~c  WhH~ rhpv l~r~rn~ 
remarkably similar to the dendritic ells found in lym- 
phoid organs t3. These observations showed that cul- 
tured Langerhans cells are m vttro equivalents of 
Langerhans cells that have ingested and processed anti- 
gen in the skin and have then migrated to the draining 
lymph node while developing into lymphoid endriuc 
cells tz~4. Indeed, this translocation of Langerhans cells 
has been documented in wvo after eDcutaneous apph- 
cation of contact allergen¢ ~a6. It would be an efficient 
mechanism for transport of anngen from the site of 
first encounter in the skin to the draining lymph node 
where a large variety of T cells can be found for in- 
ination of the specific immune response. 
Evidence for a role of Langerhans cells in leishmaniasis 
The function of Langerhans cells m vwo has been 
analysed using contact hypersensitivity and skin trans- 
plantauon as convenient models. However, the 
involvement of Langerhans cells during infectious dis- 
eases is only established for viral infections, such as 
human immunodeficiency virus and herpes simplex 
virus. With regard to skin-borne diseases caused by
intracellular bacteria or parasites, there are reports on 
the distribution and turnover of Langerhans cells ~7-19, 
but their function has not been defined. Attempts to 
address this issue by performmg manipulations that 
result in an alteration of Langerhans cell density in the 
skin (for example, ultraviolet B irradiation, tape strip- 
ping or steroid treatmenO have produced conflicting 
results depending on the type of infectious agent and 
the mode of treatment*S-2L Furthermore, the contribu- 
tion of Langerhans cells to the observed effects is diffi- 
cult to evaluate because those treatments also affect 
other components of the skin immune system. 
Parasite ingestion by Langerbans cells 
We have assessed the function of Langerhans cells in 
experimental cutaneous leishmamasis with L. major. 
Although Langerhans cells are considered to be mini- 
mally phagocytic, they express receptors for the comp- 
lement component C3bi (CR3), which opsonizes 
Lezsbmania parasites for macrophages 22"z3. This would 
favor the idea that they can interact with these organ- 
isms. Indeed, Langerhans cells were able to phagocy- 
tose intact parasites m vttro and m un]o 24. Ingestion of 
L. malor could be detected only after incubation of 
amasugotes with freshly isolated Langerhans cells, 
but not with those cultured for more than 12 h 
(suggesting that only intracutaneous Langerhans cells 
display this activity) and was mediated by the CR3. 
Thus, it is conceivable that phagocytic actlwty is not 
a general feature of a given cell type, but a property 
dependent on the state of differentiation and on 
expression of the receptors that are reqmred for 
interacuon with the respective particle. In this con- 
text, it is of interest hat Rels e Sousa nd Austyn zs 
have recently provided evidence for the abihty of 
Langerhans cells to phagocytose zymosan, the uptake 
of which correlated with the actiwty of the mannose 
receptor. Together, these findings unambiguously 
show that Langerhans cells are able to take up par- 
ucles of considerable size. 
Presentatton and transport ofL. malor by Langerbans 
cells 
As compared with macrophages, the rate of infection 
and the parasite load of L. major-contaimng Langerhans 
cells was consistently low. Th~s supports the notion 
that phagocytosis of L. malor by Langerhans cells is 
not tamed at clearance of parasites but at acquisition 
of antigen for presentauon toT cells. Such a concept is 
in concordance with our finding that epidermal 
Langerhans cells are potent stimulators of L. major- 
specific T-cell proliferation and lymphokine production 
m vttro 26. In this respect, their activity was found to be 
much greater than that of macrophages. 
In the course of infection with L. major, a dramatic 
change in the dlstribuuon of Langerhans cells was 
observed z4'27. A considerable loss of NLDC-14S" 
Langerhans cells In the segment of the epidermis over- 
lying the parasite-containing i filtrate was concomi- 
tant with the appearance of NLDC-145 + cells m the 
dermal layer of the lesion, some of which contained 
L. malor. Langerhans cells of the epidermis were found 
not to be parasitized. These observations trongly 
suggest hat Langerhans cells migrate from the epi- 
dermis to the site of mfecuon in the dermis for uptake 
of L. major parasites. Furthermore, it was possible to 
demonstrate directly by m vivo tracking that epidermal 
lmr,.notogy today 384 rot 14 No. 81993 
viewpoint 
Langerhans cells infected with L. malor have the abd~ty 
to migrate from the skin to the draining lymph 
node ~ . Such a translocauon was not seen with infected 
macrophages under simdar condlnons. The migratory 
lymph node dendrmc cells presented the transported 
antigen to L. major-primed T cells in vltro and, most 
notably, activated resting T cells capable of mediating 
a parasite-specific delayed-type hypersensltiwty re- 
sponse tn vivo. 
The model 
On these grounds, 1 propose a central role for 
Langerhans cells m the early phase of lelshmamasis 
(Fig. 1). Upon inoculation of Lelsbmanta into the 
skin, Langerhans cells migrate from the epidermis 
to the dermis and take up parasites. The signals re- 
ducing this translocatlon may be medhated by host- 
derived cytokines, such as IL-11] (Refs 28, 29) or tumor 
necrosis factor-~t (Ref. 30) and/or by parasite-derwed 
molecules. Whereas macrophages serve as scavengers 
and are the predominant site of parasite rephcation, 
the primary functmn of infected Langerhans cells 
appears to be the transport of orgamsms to the drain- 
ing lymph nodes where they encounter a large variety 
of T cells with different specificities. During migration, 
the Langerhans cells develop into potent antigen- 
presenting cells with the abdity to stimulate selected, 
bur lmmunologlcally naive, T cells for initiation of 
the immune response. As a result, activated T cells 
with specificity for Leisbmama anugens would 
emigrate via the blood into the lesion. At this site, 
infected macrophages as well as paras:re-containing 
Langerhans cells that remained in the dermis are hkely 
to present antigen to infiltrating T cells and regulate 
their effector acnwty, a process that may be enhanced 
by cascades of locally produced cytokines. 
At this point, the question arises whether Langerhans 
cells should be considered merely as a functional 
alternative to macrophages m leishmamasLs. Several 
considerations argue against his supposition: (1) the 
migratory property of Langerhans cells is a distinctive 
feature that equips them to act as an outpost of the 
immune system; (2) Langerhans cells have the capacity 
to present antigen to T cells with extraordinary 
efficiency; and (3) Langerhans cells have the unique 
ability to induce the primary activatmn of antigen- 
specific T cells. 
Thus, the involvement of Langerbans cells m initial 
events after infection may be a prerequisite for devel- 
opment of the specific cellular immune response. At 
later stages of refection, the remarkable ability of 
Langerhans cells to cluster hgh numbers of 
memory/effector T cells within the skin 3' may be 
important for maintenance of an effecnve response. 
On the other hand, macrophage functions are comp- 
lementary to those of Langerhans cells in leishmaniasls. 
Their scavenger actw~ty and abdtty, after appropriate 
activation, to produce high amounts of reactive oxygen 
and nitrogen metabolites emphasizes their role as the 
ultimate ffector cells during clearance of refection 32. It 
has yet to be determined whether Langerhans cells use 
stmilar mechantsms to control intracellular rcpl,catton 
of parasites. 
J I 
Fig. !. Hypotbet:ca! m,.'yde! of the functmna! ct;.-~t.es of Langerbans cells zn 
cutaneous lezsbmamasts. Afterdeposttton of Lelshmama promastlgotes ut the 
skin by a sandfly or by expertmental mfectton (I), Langerbans cells mrgrate 
from the epidermis to the dermis (2) and, hke macro~bages, take up 
parasaes (3) Appropriate processmg results m expression of parastte anngen 
assoaated wttb MHC class H molecules on the cell surface ( /a ). A proportton 
of Langerbans cells transports paras,tes from the infected skin to the 
draining lymph node (4) for presentatton toanttgen-spectfic restmg T cells m 
the paracortex (5). As a result, actwated T cells emtgrate t,la th blood into 
the lesion (6), where infected macropbages and Langerhans cells that remain 
in the dermts (7) regulate tbetr effector actway by sez,erat mecbamsms 
mcludmg cytokme secretmn (8) 
Implications for the course of disease 
On the basis of the findings discussed above, there 
are several ,mportant ,mplicatmns for our understand- 
lng of the pathogenes,s of cutaneous leishmamas,s. 
First, with reference to the development of TH-ceil sub- 
sets producing different arrays of lymphokines. It has 
been suggested that the type of antigen-presenting cell
determines the phenotype of responding T cells 33-3s. 
The described actwmes of Langerhans cells, however, 
can be detected in res,stant and m susceptible mice, 
although we observed ifferences in the rate of refec- 
tion (H. Moll, unpubhshed). In fact, the :niuat pre- 
dominance of L. malor-bearing dendritic ells in lymph 
nodes draining, the lesions of both types of mice 27 may 
explain our previous observation that, at the early 
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stage of mfecnon, those organs contam a comparable 
frequency of IL-4-secretmg cells ~. 
It is possible that the relative frequencies of different 
types of anngen-presenting cells, resulting m different 
densmes of hgands (MHC class lI-peptide) for the 
T-cell receptor, may mfluence the phenotype of 
responding T cells 3". In addition, the development of
T-cell subsets m wvo may not be restricted exclusively 
by the antigen-presenting cell, but may be mfluenced 
by the availabihty of co-stlmulatory stgnals (for 
example, cytokmes) from other cell types tn the 
microenvtronment 3s.39. 
A second ~mplication relates to the role of parasite 
antigens. The various types of accessory cells may dif- 
fer in their processing machinery and may thus favor 
the presentation of distinct anngens or particular epi- 
topes of a given anugen. For example, freshly isolated 
Langerhans cells reflecting the intra-epidermal stage 
were found to display numerous acid:c organelles that 
are probably involved in antigen processmg 4°.These 
organelles virtually disappear m cultured Langerhans 
cells - those that resemble lymph node dendnttc ells 
and have lost the abd~ty to process native proteins, but 
retain the ability to present peptides ~'4°. Furthermore, 
MHC class II molecules are more stable and synthesis 
of invariant chain is increased m Langerhans cells as 
compared with macrophages 4t. The slow turnover of 
MHC class II molecules is of parncular interest 
because it enables antigen-laden dendritic cells to 
retain immunogemc peptides during migration ~4. Thus, 
~t may be possible to charge Langerhans cells w~th 
purified parasite anngen ex vivo for immumzatton and 
inducnon of a protective T-cell response m s~tu. 
Certainly, a more detaded knowledge of these issues 
will be important for choosing the route and the mode 
of admimstration f protectwe antigens and, thus, the 
development of new vaccination strategies. 
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amsms underlymg the&sparate permissweness of rest- 
dent macrophages and Langerhans cells to infecuon 
with L. major and possibly other Leishmania species. 
This may help to understand the varying &sease pat- 
terns caused by different species of paras:tes and to 
approach the well-documented phenomenon of para- 
site persistence in ~mmune hosts. 
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